Mitigation of Aβ neurotoxicity in Alzheimer's disease using a non-toxic platinum complex derived from retinamide

A retinamide–platinum complex (RP) inhibits self- and metal-induced Aβ42 aggregation, reduces the generation of ROS, prevents neuroinflammation and neuronal impairment, and relieves the Aβ42-induced neurotoxicity in the AD model organism C. elegans .